Evidence map›Paper›PMID 30609757›Full record

ArticleMolecules (Basel, Switzerland)2019

The Anti-

Maciej Masłyk, Monika Janeczko, Aleksandra Martyna, Sławomir Czernik, Małgorzata Tokarska-Rodak, Marta Chwedczuk, Béatrice Foll-Josselin, Sandrine Ruchaud, Stéphane Bach, Oleg M Demchuk and 1 more

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Maciej MasłykDepartment of Molecular Biology, Institute of Biotechnology, The John Paul II Catholic University of Lublin, ul. Konstantynów 1i, 20-708 Lublin, Poland. maciekm@kul.pl.
Monika JaneczkoDepartment of Molecular Biology, Institute of Biotechnology, The John Paul II Catholic University of Lublin, ul. Konstantynów 1i, 20-708 Lublin, Poland. mjanec@kul.pl.
Aleksandra MartynaDepartment of Molecular Biology, Institute of Biotechnology, The John Paul II Catholic University of Lublin, ul. Konstantynów 1i, 20-708 Lublin, Poland. aleksandra.martyna@kul.pl.
Sławomir CzernikInnovation Research Centre, Pope John Paul II State School of Higher Education in Biala Podlaska, Sidorska 95/97, 21-500 Biala Podlaska, Poland. czernikslawomir@gmail.com.
Małgorzata Tokarska-RodakInstitute of Health Sciences, Pope John Paul II State School of Higher Education in Biala Podlaska, Sidorska 95/97, 21-500 Biala Podlaska, Poland. rodak.malgorzata@gmail.com.ORCID 0000-0003-2297-970X
Marta ChwedczukInnovation Research Centre, Pope John Paul II State School of Higher Education in Biala Podlaska, Sidorska 95/97, 21-500 Biala Podlaska, Poland. m.chwedczuk@pswbp.pl.
Béatrice Foll-JosselinSorbonne Université, USR3151 CNRS/UPMC, Plateforme de criblage KISSf (Kinase Inhibitor Specialized Screening Facility), Station Biologique, Place Georges Teissier, F-29688 Roscoff, France. beatrice.josselin@sb-roscoff.fr.
Sandrine RuchaudSorbonne Université, USR3151 CNRS/UPMC, Plateforme de criblage KISSf (Kinase Inhibitor Specialized Screening Facility), Station Biologique, Place Georges Teissier, F-29688 Roscoff, France. sandrine.ruchaud@sb-roscoff.fr.
Stéphane BachSorbonne Université, USR3151 CNRS/UPMC, Plateforme de criblage KISSf (Kinase Inhibitor Specialized Screening Facility), Station Biologique, Place Georges Teissier, F-29688 Roscoff, France. bach@sb-roscoff.fr.ORCID 0000-0002-7186-7483
Oleg M DemchukPharmaceutical Research Institute, Rydygiera Street 8, 01-793 Warsaw, Poland. O.Demchuk@IFarm.eu.ORCID 0000-0002-5571-1593
Konrad KubińskiDepartment of Molecular Biology, Institute of Biotechnology, The John Paul II Catholic University of Lublin, ul. Konstantynów 1i, 20-708 Lublin, Poland. kubin@kul.pl.ORCID 0000-0001-6870-845X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Small molecules containing quinone and/or oxime moieties have been found as promising anti-fungal agents. One of them is 4-AN, a recently reported potent anti-

Indexed as

Antifungal AgentsBiofilmsBiological TransportCandida albicansCell MembraneDrug Evaluation, PreclinicalDrug Resistance, MicrobialHumansMicrobial Sensitivity TestsModels, MolecularMolecular StructureOximesPhosphorylationProtein BindingProtein Kinase InhibitorsQuinonesAntifungal AgentsOximesProtein Kinase InhibitorsQuinones4-ANantifungal agentarylcyanomethylenequinonesatomic force microscopyCandida albicansprotein kinases

Identifiers

PMID30609757
PMCPMC6337409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.